The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, BioSpecifics Technologies's share price is $88.53.
BioSpecifics Technologies's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2020 was $4.97. Hence, BioSpecifics Technologies's PS Ratio for today is 17.82.
Warning Sign:
BioSpecifics Technologies Corp stock PS Ratio (=16.61) is close to 5-year high of 16.95
The historical rank and industry rank for BioSpecifics Technologies's PS Ratio or its related term are showing as below:
BSTC'
s PS Ratio Range Over the Past 10 Years
Min: 8.65 Med: 12.76 Max: 27.1
Current: 16.61
During the past 13 years, BioSpecifics Technologies's highest PS Ratio was 27.10. The lowest was 8.65. And the median was 12.76.
BSTC's PS Ratio is not ranked
in the Biotechnology industry.
Industry Median: 8.98
vs BSTC: 16.61
BioSpecifics Technologies Corp revenue growth has slowed down over the past 12 months.
During the past 12 months, the average Revenue per Share Growth Rate of BioSpecifics Technologies was 0.10% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 11.00% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 19.40% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 26.00% per year.
During the past 13 years, BioSpecifics Technologies's highest 3-Year average Revenue per Share Growth Rate was 58.20% per year. The lowest was -51.80% per year. And the median was 11.00% per year.
Back to Basics: PS Ratio
BioSpecifics Technologies PS Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of BioSpecifics Technologies's PS Ratio
For the Biotechnology subindustry, BioSpecifics Technologies's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BioSpecifics Technologies's PS Ratio Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, BioSpecifics Technologies's PS Ratio distribution charts can be found below:
* The bar in red indicates where BioSpecifics Technologies's PS Ratio falls into.
BioSpecifics Technologies PS Ratio Calculation
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
BioSpecifics Technologies's Share Price of today is $88.53. BioSpecifics Technologies's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was $4.97.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
BioSpecifics Technologies (NAS:BSTC) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
BioSpecifics Technologies PS Ratio Related Terms
Thank you for viewing the detailed overview of BioSpecifics Technologies's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
BioSpecifics Technologies (BioSpecifics Technologies) Business Description
BioSpecifics Technologies Corp is a biopharmaceutical company that specializes in collagenase for multiple indications. Injectable collagenase is marketed in various geographic regions, including the U.S., the EU, and Australia, under the Xiaflex name. The targeted diseases are Dupuytren's contracture and Peyronie's disease. The company is also researching the development of Xiaflex as a solution for new potential indications, such as uterine fibroids, adhesive capsulitis, cellulite, lateral hip fat, plantar fibromatosis, and human and canine lipomas.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BSTC has been successfully added to your 